Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azra C Ghani

Showing results (31-40 of 174) with videos related to

Pageof 18
Sort By:
BMJ Global Health|June 8, 2017
Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan AfricaPeter Winskill, Patrick Gt Walker, Jamie T Griffin, et al.
Malaria Journal|April 10, 2019
Prioritizing the scale-up of interventions for malaria control and eliminationPeter Winskill, Patrick G Walker, Richard E Cibulskis, et al.
Statistical Methods in Medical Research|June 28, 2003
Short-term projections for variant Creutzfeldt-Jakob disease onsetsAzra C Ghani, Neil M Ferguson, Christl A Donnelly, et al.
Comptes Rendus Biologies|February 28, 2002
The transmission dynamics of BSE and vCJDAzra C Ghani, Christl A Donnelly, Neil M Ferguson, et al.
BMC Infectious Diseases|April 30, 2003
Updated projections of future vCJD deaths in the UKAzra C Ghani, Christl A Donnelly, Neil M Ferguson, et al.
Proceedings. Biological Sciences|April 26, 2003
Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UKAzra C Ghani, Neil M Ferguson, Christl A Donnelly, et al.
Malaria Journal|March 25, 2010
Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trialsMichael T White, Jamie T Griffin, Chris J Drakeley, et al.
Malaria Journal|January 8, 2016
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan AfricaHannah C Slater, Jamie T Griffin, Azra C Ghani, et al.
Proceedings. Biological Sciences|April 1, 2016
Variation in relapse frequency and the transmission potential of Plasmodium vivax malariaMichael T White, George Shirreff, Stephan Karl, et al.
Proceedings. Biological Sciences|November 13, 2002
Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levelsChristl A Donnelly, Neil M Ferguson, Azra C Ghani, et al.
Pageof 18

Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
BMJ Global Health|June 8, 2017
Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan AfricaPeter Winskill, Patrick Gt Walker, Jamie T Griffin, et al.
Malaria Journal|April 10, 2019
Prioritizing the scale-up of interventions for malaria control and eliminationPeter Winskill, Patrick G Walker, Richard E Cibulskis, et al.
Statistical Methods in Medical Research|June 28, 2003
Short-term projections for variant Creutzfeldt-Jakob disease onsetsAzra C Ghani, Neil M Ferguson, Christl A Donnelly, et al.
Comptes Rendus Biologies|February 28, 2002
The transmission dynamics of BSE and vCJDAzra C Ghani, Christl A Donnelly, Neil M Ferguson, et al.
BMC Infectious Diseases|April 30, 2003
Updated projections of future vCJD deaths in the UKAzra C Ghani, Christl A Donnelly, Neil M Ferguson, et al.
Proceedings. Biological Sciences|April 26, 2003
Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UKAzra C Ghani, Neil M Ferguson, Christl A Donnelly, et al.
Malaria Journal|March 25, 2010
Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trialsMichael T White, Jamie T Griffin, Chris J Drakeley, et al.
Malaria Journal|January 8, 2016
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan AfricaHannah C Slater, Jamie T Griffin, Azra C Ghani, et al.
Proceedings. Biological Sciences|April 1, 2016
Variation in relapse frequency and the transmission potential of Plasmodium vivax malariaMichael T White, George Shirreff, Stephan Karl, et al.
Proceedings. Biological Sciences|November 13, 2002
Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levelsChristl A Donnelly, Neil M Ferguson, Azra C Ghani, et al.
Pageof 18